The Small Business Innovation Research (SBIR) is one of the largest sources of early-stage capital for technology commercialization in the United States. NIH’s SBIR program invests over 1 billion dollars [….]
In Conversation: Sally Allain, Head, JLABS @ Washington, DC – Johnson & Johnson Innovation BioBuzz recently caught up with the Head of JLABS @ Washington, DC, Sally Allain, to discuss [….]
Who runs the healthcare world? Women make 80% of all buying decisions and make up over 70% of the healthcare workforce—yet in 2020 we still do not have an equal [….]
Developing medication, devices, and products for children is not a matter of “shrinking” down the adult version. Delivering solutions to our littlest patients requires a long-term approach that deliberately centers [….]
6 People in the BioHealth Capital Region You Should Know In 2020 2019 was a year of change for many BioHealth Capital Region organizations. The past year has seen a [….]
Antimicrobial resistance (AMR) is in the news lately and for good reason. Diseases that were once easy to treat are becoming increasingly difficult to cure. But the largest contributor to [….]
Representatives from Johnson & Johnson Innovation will provide an overview of goals and mission, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation [….]
The new Children’s National Innovation Campus with JLABS-DC, part of the Walter Reed Redevelopment project in NW Washington DC.
2019 BioHealth Capital Region Forum Insights and Key Takeaways April 10, 2019 The 5th annual Biohealth Capital Region (BHCR) Forum was held on April 8th and 9th at AstraZeneca in [….]
